These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29352025)

  • 1. State-of-the-art and future directions for extinction as a translational model for fear and anxiety.
    Craske MG; Hermans D; Vervliet B
    Philos Trans R Soc Lond B Biol Sci; 2018 Mar; 373(1742):. PubMed ID: 29352025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing exposure therapy with an inhibitory retrieval approach and the OptEx Nexus.
    Craske MG; Treanor M; Zbozinek TD; Vervliet B
    Behav Res Ther; 2022 May; 152():104069. PubMed ID: 35325683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How can neurobiology of fear extinction inform treatment?
    Craske MG; Sandman CF; Stein MB
    Neurosci Biobehav Rev; 2022 Dec; 143():104923. PubMed ID: 36280184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reward processes in extinction learning and applications to exposure therapy.
    Rosenberg BM; Barnes-Horowitz NM; Zbozinek TD; Craske MG
    J Anxiety Disord; 2024 Aug; 106():102911. PubMed ID: 39128178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renewal of fear and avoidance in humans to escalating threat: Implications for translational research on anxiety disorders.
    Schlund MW; Ludlum M; Magee SK; Tone EB; Brewer A; Richman DM; Dymond S
    J Exp Anal Behav; 2020 Jan; 113(1):153-171. PubMed ID: 31803943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of associative fear and avoidance learning in anxiety disorders: Gaps and directions for future research.
    Pittig A; Treanor M; LeBeau RT; Craske MG
    Neurosci Biobehav Rev; 2018 May; 88():117-140. PubMed ID: 29550209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The key role of extinction learning in anxiety disorders: behavioral strategies to enhance exposure-based treatments.
    Pittig A; van den Berg L; Vervliet B
    Curr Opin Psychiatry; 2016 Jan; 29(1):39-47. PubMed ID: 26575298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing exposure therapy: an inhibitory learning approach.
    Craske MG; Treanor M; Conway CC; Zbozinek T; Vervliet B
    Behav Res Ther; 2014 Jul; 58():10-23. PubMed ID: 24864005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pavlovian extinction of fear with the original conditional stimulus, a generalization stimulus, or multiple generalization stimuli.
    Zbozinek TD; Craske MG
    Behav Res Ther; 2018 Aug; 107():64-75. PubMed ID: 29879536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A translational perspective on neural circuits of fear extinction: Current promises and challenges.
    Sevenster D; Visser RM; D'Hooge R
    Neurobiol Learn Mem; 2018 Nov; 155():113-126. PubMed ID: 29981423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice.
    Zhang G; Ásgeirsdóttir HN; Cohen SJ; Munchow AH; Barrera MP; Stackman RW
    Neuropharmacology; 2013 Jan; 64(1):403-13. PubMed ID: 22722027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiology of anxiety disorders and implications for treatment.
    Garakani A; Mathew SJ; Charney DS
    Mt Sinai J Med; 2006 Nov; 73(7):941-9. PubMed ID: 17195879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of prediction error and memory destabilization in extinction of cued-fear within the reconsolidation window.
    Cahill EN; Wood MA; Everitt BJ; Milton AL
    Neuropsychopharmacology; 2019 Sep; 44(10):1762-1768. PubMed ID: 30659275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of Extinction and Inhibitory Learning in Anxiety and Trauma-Related Disorders.
    Lebois LAM; Seligowski AV; Wolff JD; Hill SB; Ressler KJ
    Annu Rev Clin Psychol; 2019 May; 15():257-284. PubMed ID: 30698994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing inhibitory learning during exposure therapy.
    Craske MG; Kircanski K; Zelikowsky M; Mystkowski J; Chowdhury N; Baker A
    Behav Res Ther; 2008 Jan; 46(1):5-27. PubMed ID: 18005936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular specificity of multiple hippocampal processes governing fear extinction.
    Radulovic J; Tronson NC
    Rev Neurosci; 2010; 21(1):1-17. PubMed ID: 20458884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders.
    Hofmann SG
    Clin Psychol Rev; 2008 Feb; 28(2):199-210. PubMed ID: 17532105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model.
    Whittle N; Schmuckermair C; Gunduz Cinar O; Hauschild M; Ferraguti F; Holmes A; Singewald N
    Neuropharmacology; 2013 Jan; 64(4):414-23. PubMed ID: 22722028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroscience of fear extinction: implications for assessment and treatment of fear-based and anxiety related disorders.
    Milad MR; Rosenbaum BL; Simon NM
    Behav Res Ther; 2014 Nov; 62():17-23. PubMed ID: 25204715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming avoidance in anxiety disorders: The contributions of Pavlovian and operant avoidance extinction methods.
    Dymond S
    Neurosci Biobehav Rev; 2019 Mar; 98():61-70. PubMed ID: 30629978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.